Cogent Biosciences, Inc. (COGT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-51.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $7.87M | $22.50M | $9.73M | $8.36M | — |
| Operating Income | -$333.36M | -$275.94M | -$208.13M | -$147.84M | -$75.55M | -$82.20M | -$32.18M | -$36.01M | -$26.15M | — |
| Net Income | -$328.94M | -$255.86M | -$192.41M | -$140.24M | -$72.27M | -$74.81M | -$31.83M | -$34.53M | -$25.49M | — |
| EPS (Diluted) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | — | — | — | — | — |
| Total Assets | $937.61M | $327.90M | $313.44M | $300.81M | $232.09M | $250.92M | $49.42M | $85.93M | $49.12M | — |
| Total Liabilities | $301.24M | $71.61M | $55.63M | $45.08M | $17.91M | $16.25M | $17.66M | $25.69M | $20.81M | — |
| Shareholders' Equity | $636.37M | $256.29M | $257.80M | $255.74M | $214.18M | $234.67M | $31.76M | $60.23M | -$48.85M | -$24.70M |
| Cash & Equivalents | $312.01M | $98.17M | $53.23M | $139.89M | $219.68M | $242.19M | $37.42M | $55.67M | $28.27M | — |
| Operating Cash Flow | -$264.44M | -$207.79M | -$153.62M | -$118.64M | -$58.76M | -$35.85M | -$41.51M | -$32.49M | -$25.84M | — |
| Capital Expenditures | $1.55M | $573.0K | $2.80M | $6.86M | $1.72M | — | $33.0K | $549.0K | $912.0K | — |
| Shares Outstanding | 160.98M | 110.46M | 86.12M | 69.89M | 43.81M | 32.35M | 7.67M | 30.06M | 10.20M | — |